Heartbeat: sex differences in patient-reported outcomes with atrial fibrillation

Patient-reported outcome measures (PROMs) now are recognised as an essential element in clinical cardiovascular research studies. In addition, we are increasing aware of significant sex differences, not only in risk factors, clinical presentation and outcomes, but in the treatments provided to patients with cardiovascular disease. In this issue of Heart , a study by Gleason and colleagues1 compared atrial fibrillation (AF) therapy and PROMs in...